PainReform Ltd. (PRFX)
PRFX Stock Price Chart
Explore PainReform Ltd. interactive price chart. Choose custom timeframes to analyze PRFX price movements and trends.
PRFX Company Profile
Discover essential business fundamentals and corporate details for PainReform Ltd. (PRFX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1 Sept 2020
Employees
2.00
Website
https://www.painreform.comCEO
Ehud Geller
Description
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.
PRFX Financial Timeline
Browse a chronological timeline of PainReform Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 11 Sept 2025
Earnings released on 28 Aug 2025
EPS came in at -$9.60 .
Earnings released on 7 Apr 2025
EPS came in at -$0.60 .
Earnings released on 2 Apr 2025
Stock split effective on 21 Nov 2024
Shares were split 1 : 4 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 19 Nov 2024
EPS came in at -$0.60 surpassing the estimated -$4.74 by +87.31%.
Stock split effective on 9 Sept 2024
Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 Aug 2024
EPS came in at -$9.60 falling short of the estimated -$6.24 by -53.85%.
Earnings released on 15 May 2024
EPS came in at -$65.27 falling short of the estimated -$2.40 by -2.62K%, while revenue for the quarter reached $0.00 .
Earnings released on 29 Feb 2024
EPS came in at -$83.98 falling short of the estimated -$1.49 by -5.54K%.
Earnings released on 15 Nov 2023
EPS came in at $11.52 surpassing the estimated -$1.40 by +922.86%.
Earnings released on 10 Aug 2023
EPS came in at -$48.82 surpassing the estimated -$60.00 by +18.63%.
Stock split effective on 3 Jul 2023
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 May 2023
EPS came in at -$52.79 surpassing the estimated -$52.80 by +0.02%.
Earnings released on 16 Mar 2023
EPS came in at -$69.59 falling short of the estimated -$36.00 by -93.31%, while revenue for the quarter reached $86.00K .
Earnings released on 15 Nov 2022
EPS came in at -$47.99 falling short of the estimated -$40.80 by -17.62%.
Earnings released on 15 Aug 2022
EPS came in at -$40.79 falling short of the estimated -$0.16 by -25.39K%.
Earnings released on 16 May 2022
EPS came in at -$38.39 falling short of the estimated -$1.60 by -2.30K%.
Earnings released on 17 Mar 2022
EPS came in at -$0.17 surpassing the estimated -$0.55 by +69.09%.
Earnings released on 15 Nov 2021
EPS came in at -$43.19 falling short of the estimated -$0.43 by -9.94K%.
Earnings released on 16 Aug 2021
EPS came in at -$40.79 falling short of the estimated -$0.51 by -7.90K%.
Earnings released on 13 May 2021
EPS came in at -$55.19 falling short of the estimated -$0.56 by -9.76K%.
Earnings released on 18 Mar 2021
EPS came in at -$27.43 .
Earnings released on 30 Sept 2020
EPS came in at -$17.94 .
Earnings released on 30 Sept 2020
EPS came in at -$29.33 .
PRFX Stock Performance
Access detailed PRFX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.